Medical advancements show promise in Alzheimer's care and brain tumor monitoring

Recent medical research has highlighted new developments in treating Alzheimer's disease and monitoring aggressive brain tumors.

A large-scale Swedish study conducted by the Karolinska Institutet examined data from over 7,000 patients diagnosed with both Alzheimer's and atrial fibrillation. The findings suggest that patients using newer types of oral anticoagulants, known as NOACs, may experience a slower decline in cognitive abilities compared to those treated with warfarin or no anticoagulants. While the study does not prove a direct medicinal effect on Alzheimer's, researchers suggest the benefit may stem from the protection of cerebral blood vessels.

In a separate breakthrough, researchers at the California Institute of Technology (Caltech) have developed a pioneering ultrasound technique to monitor the real-time growth of glioblastoma, the most aggressive form of brain cancer. Published in the journal iScience, the method allows scientists to observe how tumors reshape the brain and its vascular system in three dimensions within living organisms. This advancement addresses previous limitations of MRI and optical imaging, potentially aiding in the development of more effective neuro-oncological treatments.